Episode Synopsis "Closing Lunch, David Mott, General Partner, NEA, former CEO of MedImmune"

Conference Audio

Listen "Closing Lunch, David Mott, General Partner, NEA, former CEO of MedImmune"

More episodes of the podcast CED Biotech 2011

• Scott Evangelista, Comparative Effectiveness - A Driver for Enhanced Competitiveness
• Closing Lunch, David Mott, General Partner, NEA, former CEO of MedImmune
• Opening Remarks and Featured Speaker David P. King, Chairman and CEO, LabCorp
• Personalized Medicine Panel, Timing is everything - What you know and don't know in co-development
• Financing Panel: State of Capital Markets and Changing Funding Model
• Opening Remarks The Honorable Beverly Eaves Perdue, Governor of North Carolina
• Deirdre P. Connelly, President, North America Pharmaceuticals, GlaxoSmithKline
• Featured Speaker and Special Report Robert Cascella, President and CEO, Hologic